The University of Chicago Header Logo

Daniel W. Golden

Concepts (337)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology
48
2023
119
19.200
Why?
Students, Medical
17
2023
385
5.400
Why?
Curriculum
22
2024
542
5.260
Why?
Internship and Residency
24
2023
1010
3.990
Why?
Clinical Clerkship
9
2018
116
3.640
Why?
Program Evaluation
10
2020
297
1.990
Why?
Clinical Competence
12
2023
756
1.980
Why?
Education, Medical, Undergraduate
6
2019
160
1.980
Why?
Brachytherapy
5
2023
119
1.890
Why?
Needs Assessment
6
2021
154
1.810
Why?
Career Choice
7
2020
141
1.790
Why?
Chemoradiotherapy
6
2020
301
1.780
Why?
Medical Oncology
5
2024
360
1.610
Why?
Surveys and Questionnaires
24
2022
2502
1.570
Why?
Radiotherapy Planning, Computer-Assisted
8
2020
176
1.540
Why?
Interprofessional Relations
3
2021
121
1.530
Why?
Education, Medical, Graduate
7
2023
373
1.310
Why?
Patient Education as Topic
4
2023
351
1.290
Why?
Educational Measurement
8
2019
226
1.260
Why?
Radiation Oncologists
5
2022
13
1.220
Why?
Reading
2
2019
30
1.200
Why?
Radiotherapy, Conformal
3
2020
83
1.180
Why?
Health Literacy
3
2023
69
1.150
Why?
Uterine Cervical Neoplasms
4
2023
275
1.110
Why?
Humans
83
2024
86656
1.060
Why?
School Admission Criteria
2
2016
23
1.020
Why?
United States
23
2023
6674
0.990
Why?
Schools, Medical
3
2023
123
0.980
Why?
Education, Nursing
2
2021
10
0.980
Why?
Radiotherapy Dosage
7
2023
468
0.960
Why?
Internet
5
2018
312
0.910
Why?
Neoplasms
5
2023
2898
0.870
Why?
Interdisciplinary Studies
2
2019
20
0.840
Why?
Radiotherapy, Image-Guided
3
2021
56
0.830
Why?
Radiotherapy, Intensity-Modulated
3
2020
173
0.800
Why?
Integrative Medicine
1
2021
8
0.790
Why?
Medical Staff
1
2021
10
0.780
Why?
Interdisciplinary Communication
2
2021
130
0.770
Why?
Virtual Reality
1
2020
21
0.760
Why?
Complementary Therapies
1
2021
54
0.750
Why?
Mentoring
1
2021
30
0.740
Why?
Patient Care Team
2
2021
280
0.740
Why?
Adenocarcinoma
3
2019
1169
0.730
Why?
Congresses as Topic
1
2020
116
0.730
Why?
Radiosurgery
3
2013
272
0.720
Why?
Physicians
3
2024
673
0.650
Why?
Palliative Medicine
1
2018
11
0.650
Why?
Female
34
2023
44566
0.620
Why?
Carcinoma, Squamous Cell
3
2020
1077
0.610
Why?
Elbow Joint
2
2008
29
0.590
Why?
Male
32
2021
40995
0.580
Why?
Range of Motion, Articular
2
2008
148
0.580
Why?
Simulation Training
1
2018
88
0.580
Why?
Patient-Centered Care
1
2019
203
0.570
Why?
Nasopharyngeal Neoplasms
2
2016
47
0.570
Why?
Academic Medical Centers
2
2018
378
0.550
Why?
Pamphlets
1
2015
14
0.520
Why?
Teaching
1
2016
147
0.520
Why?
Carcinoma, Non-Small-Cell Lung
3
2019
1075
0.510
Why?
Fluorouracil
3
2016
556
0.510
Why?
Adult
20
2021
25648
0.470
Why?
Pediatrics
1
2018
344
0.470
Why?
Health Knowledge, Attitudes, Practice
1
2018
508
0.470
Why?
CA-19-9 Antigen
1
2012
11
0.440
Why?
Lung Neoplasms
4
2019
2262
0.430
Why?
Pilot Projects
4
2020
840
0.420
Why?
Carcinoma
2
2012
436
0.420
Why?
Prostatic Neoplasms
3
2021
1721
0.420
Why?
Research
2
2013
253
0.420
Why?
Induction Chemotherapy
1
2012
147
0.410
Why?
Program Development
4
2021
125
0.370
Why?
Young Adult
7
2019
5977
0.350
Why?
Cross-Sectional Studies
7
2022
1618
0.350
Why?
Incidental Findings
2
2020
95
0.350
Why?
Comprehension
3
2023
79
0.350
Why?
Carcinoma, Renal Cell
1
2013
424
0.350
Why?
Lymphatic Metastasis
3
2020
486
0.340
Why?
Consensus
3
2022
336
0.330
Why?
Canada
4
2022
202
0.320
Why?
Kidney Neoplasms
1
2013
619
0.320
Why?
Neoplasm Staging
6
2021
1938
0.300
Why?
Ulna
1
2007
13
0.300
Why?
Humerus
1
2007
29
0.300
Why?
Education, Medical
2
2024
234
0.290
Why?
Overweight
1
2008
118
0.290
Why?
Pancreatic Neoplasms
1
2012
645
0.290
Why?
Aged
11
2021
18407
0.280
Why?
Data Collection
3
2018
372
0.270
Why?
Middle Aged
14
2021
25027
0.250
Why?
Biomarkers, Tumor
1
2012
1464
0.240
Why?
Body Mass Index
1
2008
768
0.240
Why?
Brain Neoplasms
2
2014
763
0.240
Why?
Child
8
2021
6933
0.240
Why?
Radiotherapy, Adjuvant
2
2019
292
0.240
Why?
Organs at Risk
2
2020
41
0.230
Why?
Quality of Life
2
2021
1587
0.220
Why?
Delphi Technique
1
2022
80
0.220
Why?
Kaplan-Meier Estimate
3
2013
861
0.210
Why?
Teaching Rounds
2
2020
24
0.210
Why?
Genital Neoplasms, Female
1
2023
107
0.200
Why?
Chi-Square Distribution
2
2020
364
0.200
Why?
Chicago
2
2018
1380
0.200
Why?
Faculty, Medical
2
2020
178
0.200
Why?
Controlled Before-After Studies
1
2021
3
0.200
Why?
Cohort Studies
3
2021
2765
0.200
Why?
Intersectoral Collaboration
1
2020
10
0.190
Why?
Retrospective Studies
8
2021
8476
0.190
Why?
Second-Look Surgery
1
2020
4
0.190
Why?
Hemoglobin A
1
2020
8
0.190
Why?
Salpingo-oophorectomy
1
2020
3
0.190
Why?
Academies and Institutes
1
2021
31
0.190
Why?
Chemotherapy, Adjuvant
2
2012
468
0.190
Why?
Oncologists
1
2021
36
0.190
Why?
Professional Role
1
2021
41
0.190
Why?
Margins of Excision
1
2020
39
0.190
Why?
Radiation Dosage
1
2021
225
0.190
Why?
Mentors
2
2019
76
0.190
Why?
Feedback
1
2021
132
0.190
Why?
Information Seeking Behavior
1
2020
12
0.180
Why?
Human papillomavirus 18
1
2020
16
0.180
Why?
Vaccines, DNA
1
2020
18
0.180
Why?
Aged, 80 and over
5
2017
6511
0.180
Why?
Professionalism
1
2020
24
0.180
Why?
Human papillomavirus 16
1
2020
38
0.180
Why?
Treatment Outcome
6
2017
7982
0.180
Why?
Smartphone
1
2020
36
0.180
Why?
Pandemics
2
2023
737
0.180
Why?
Learning
1
2023
281
0.180
Why?
Pain Management
1
2021
126
0.180
Why?
Printing, Three-Dimensional
1
2020
37
0.180
Why?
Qualitative Research
1
2021
256
0.180
Why?
Self Care
1
2021
164
0.180
Why?
Cooperative Behavior
1
2021
176
0.180
Why?
Follow-Up Studies
4
2017
3639
0.180
Why?
Hysterectomy
1
2020
146
0.180
Why?
Mediastinum
1
2019
46
0.170
Why?
Safety
1
2020
152
0.170
Why?
Time Factors
5
2020
5215
0.170
Why?
Models, Educational
1
2019
50
0.170
Why?
Nurse Practitioners
1
2019
32
0.170
Why?
Neoplasm Invasiveness
1
2020
552
0.170
Why?
Self-Assessment
1
2018
47
0.170
Why?
Positron Emission Tomography Computed Tomography
1
2019
86
0.160
Why?
Training Support
1
2018
23
0.160
Why?
Survival Rate
3
2012
1864
0.160
Why?
Neoplasm Recurrence, Local
3
2017
1313
0.160
Why?
Manikins
1
2018
41
0.160
Why?
Patient Simulation
1
2018
42
0.160
Why?
Solitary Pulmonary Nodule
1
2019
138
0.160
Why?
Postoperative Care
1
2019
221
0.160
Why?
Workload
1
2019
128
0.160
Why?
Computer-Assisted Instruction
1
2018
43
0.160
Why?
Phantoms, Imaging
1
2020
429
0.160
Why?
Informed Consent
1
2020
266
0.160
Why?
Hospitals, Teaching
2
2019
116
0.150
Why?
Ethics, Medical
1
2020
306
0.150
Why?
Communication
1
2021
440
0.150
Why?
Prostate-Specific Antigen
1
2019
353
0.150
Why?
Universities
1
2018
135
0.150
Why?
Pneumonectomy
1
2019
196
0.150
Why?
Medical Illustration
1
2016
16
0.150
Why?
Child, Preschool
5
2021
3612
0.150
Why?
Radiation Injuries
2
2016
156
0.140
Why?
Endosonography
1
2017
96
0.140
Why?
Leukopenia
1
2016
65
0.140
Why?
Job Satisfaction
1
2017
73
0.140
Why?
General Surgery
1
2019
229
0.140
Why?
Anus Neoplasms
1
2016
30
0.140
Why?
Capecitabine
2
2016
96
0.140
Why?
Pelvic Bones
1
2016
43
0.140
Why?
Bronchi
1
2017
229
0.140
Why?
Delivery of Health Care
1
2021
426
0.140
Why?
Texas
1
2016
101
0.140
Why?
Adolescent
5
2021
8988
0.140
Why?
Radiation, Ionizing
2
2014
121
0.140
Why?
Clinical Decision-Making
1
2018
257
0.140
Why?
Biomechanical Phenomena
2
2008
457
0.130
Why?
Early Detection of Cancer
1
2019
395
0.130
Why?
Lymph Nodes
1
2019
533
0.130
Why?
Societies, Medical
2
2019
573
0.130
Why?
Robotic Surgical Procedures
1
2020
267
0.130
Why?
Thrombocytopenia
1
2016
183
0.130
Why?
Erythrocyte Transfusion
2
2010
60
0.130
Why?
Dose-Response Relationship, Radiation
2
2012
188
0.130
Why?
Bone Marrow
1
2016
435
0.130
Why?
Radiotherapy
1
2016
328
0.120
Why?
Esophagitis
1
2014
43
0.120
Why?
Breast Neoplasms
3
2016
2904
0.120
Why?
Boston
1
2014
33
0.120
Why?
Radiation-Sensitizing Agents
1
2014
95
0.120
Why?
Job Application
1
2013
8
0.120
Why?
Consumer Behavior
1
2014
29
0.120
Why?
RNA Helicases
1
2014
35
0.120
Why?
Personnel Selection
1
2014
59
0.120
Why?
DEAD-box RNA Helicases
1
2014
62
0.110
Why?
Self Concept
1
2014
133
0.110
Why?
Skin
1
2016
554
0.110
Why?
Sirolimus
1
2014
170
0.110
Why?
Disease-Free Survival
2
2013
1204
0.110
Why?
Social Networking
1
2013
75
0.110
Why?
Metalloporphyrins
1
2012
26
0.110
Why?
Fatigue
1
2013
175
0.110
Why?
Platinum
1
2012
63
0.110
Why?
Hydroxyurea
1
2012
239
0.110
Why?
Adrenal Gland Neoplasms
1
2013
80
0.110
Why?
Neoplasms, Experimental
1
2014
269
0.100
Why?
Carcinoma, Large Cell
1
2012
39
0.100
Why?
Sensitivity and Specificity
1
2016
1991
0.100
Why?
Tomography, X-Ray Computed
1
2021
2585
0.100
Why?
Cell Survival
1
2014
971
0.100
Why?
Deoxycytidine
1
2012
237
0.100
Why?
Genetic Vectors
1
2012
440
0.100
Why?
Remission Induction
1
2012
722
0.100
Why?
Quality Improvement
1
2014
427
0.100
Why?
Genetic Therapy
1
2012
343
0.090
Why?
Exhalation
1
2010
7
0.090
Why?
Hemoglobinopathies
1
2010
10
0.090
Why?
Neoadjuvant Therapy
1
2012
318
0.090
Why?
Prospective Studies
5
2021
4212
0.090
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2010
72
0.090
Why?
Reproducibility of Results
1
2016
2704
0.090
Why?
Carbon Monoxide
1
2010
90
0.090
Why?
Thyroid Neoplasms
1
2014
408
0.090
Why?
STAT1 Transcription Factor
1
2009
52
0.090
Why?
Infant
3
2021
3048
0.090
Why?
Benzimidazoles
1
2010
140
0.090
Why?
Tumor Necrosis Factor-alpha
1
2012
685
0.080
Why?
Elbow
1
2008
12
0.080
Why?
Lifting
1
2008
12
0.080
Why?
Disease Progression
1
2012
1534
0.080
Why?
Salaries and Fringe Benefits
2
2020
22
0.080
Why?
Enzyme Inhibitors
1
2010
639
0.070
Why?
Feasibility Studies
2
2021
751
0.070
Why?
Folic Acid
1
2007
60
0.070
Why?
Linear Models
1
2008
421
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2016
2438
0.070
Why?
Animals
4
2020
26706
0.070
Why?
Chromosome Aberrations
1
2007
387
0.070
Why?
Prognosis
2
2012
3681
0.060
Why?
Melanoma
1
2008
459
0.060
Why?
Anemia, Sickle Cell
2
2010
131
0.060
Why?
Translating
1
2023
18
0.060
Why?
Cultural Competency
1
2023
21
0.060
Why?
Competency-Based Education
1
2023
35
0.050
Why?
Accreditation
1
2023
60
0.050
Why?
Peer Review
1
2022
23
0.050
Why?
Age Factors
1
2007
1849
0.050
Why?
Attitude
1
2022
127
0.050
Why?
Language
1
2023
151
0.050
Why?
Patient Care Planning
1
2021
81
0.050
Why?
Iron Overload
1
2000
6
0.050
Why?
Crohn Disease
1
2007
731
0.050
Why?
Papillomavirus E7 Proteins
1
2020
31
0.050
Why?
Antineoplastic Agents, Hormonal
1
2021
150
0.050
Why?
Oncogene Proteins, Viral
1
2020
34
0.050
Why?
Androgen Antagonists
1
2021
144
0.050
Why?
Perception
1
2021
168
0.050
Why?
Uterus
1
2021
215
0.050
Why?
Colitis, Ulcerative
1
2007
711
0.050
Why?
Sex Distribution
1
2020
173
0.040
Why?
Personal Satisfaction
1
2020
62
0.040
Why?
Personnel Delegation
1
2019
1
0.040
Why?
Iron
1
2000
164
0.040
Why?
Nigeria
1
2020
152
0.040
Why?
Preventive Health Services
1
2019
37
0.040
Why?
Hospitals, University
1
2020
194
0.040
Why?
Advisory Committees
1
2019
90
0.040
Why?
Time-to-Treatment
1
2020
98
0.040
Why?
Trauma Centers
1
2019
115
0.040
Why?
Risk Factors
1
2008
5416
0.040
Why?
Registries
1
2021
703
0.040
Why?
Comorbidity
1
2021
945
0.040
Why?
Mitomycin
1
2016
29
0.040
Why?
Repressor Proteins
1
2020
405
0.040
Why?
Sex Factors
1
2020
1053
0.040
Why?
Ilium
1
2016
18
0.040
Why?
Parotid Gland
1
2016
31
0.040
Why?
Transcriptome
1
2021
580
0.040
Why?
Cochlea
1
2016
50
0.040
Why?
Neutropenia
1
2016
215
0.030
Why?
Tumor Burden
1
2016
290
0.030
Why?
Incidence
1
2019
1578
0.030
Why?
Apoptosis
2
2014
1689
0.030
Why?
Drug Administration Schedule
1
2016
915
0.030
Why?
Physician-Patient Relations
1
2020
610
0.030
Why?
Decision Making
1
2020
643
0.030
Why?
Mastectomy
1
2016
243
0.030
Why?
Practice Guidelines as Topic
1
2021
1037
0.030
Why?
DEAD Box Protein 58
1
2014
11
0.030
Why?
DNA-Binding Proteins
1
2020
1214
0.030
Why?
Family Characteristics
1
2013
48
0.030
Why?
Survival Analysis
1
2017
1540
0.030
Why?
Fatal Outcome
1
2014
295
0.030
Why?
Mice
3
2014
11439
0.030
Why?
Interferon Type I
1
2014
175
0.030
Why?
Tumor Cells, Cultured
1
2014
1041
0.030
Why?
Glioblastoma
1
2014
255
0.030
Why?
Infrared Rays
1
2010
17
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2010
11
0.020
Why?
Neuroblastoma
1
2014
375
0.020
Why?
Cell Growth Processes
1
2010
83
0.020
Why?
Thalassemia
1
2010
16
0.020
Why?
Breath Tests
1
2010
55
0.020
Why?
Carcinoma, Hepatocellular
1
2014
386
0.020
Why?
Cellular Senescence
1
2010
94
0.020
Why?
Green Fluorescent Proteins
1
2010
306
0.020
Why?
Mice, Knockout
1
2014
1944
0.020
Why?
Xenograft Model Antitumor Assays
1
2010
458
0.020
Why?
Melanoma, Experimental
1
2009
103
0.020
Why?
Neoplasm Transplantation
1
2009
392
0.020
Why?
Mice, Nude
1
2010
789
0.020
Why?
Recombinant Fusion Proteins
1
2010
560
0.020
Why?
Doxorubicin
1
2009
295
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2010
382
0.020
Why?
Liver Neoplasms
1
2014
736
0.020
Why?
Micronucleus Tests
1
2007
5
0.020
Why?
Interferon-gamma
1
2009
445
0.020
Why?
Longitudinal Studies
1
2010
1019
0.020
Why?
Combined Modality Therapy
1
2010
1686
0.020
Why?
Image Processing, Computer-Assisted
1
2012
1205
0.020
Why?
Predictive Value of Tests
1
2010
1672
0.020
Why?
Antineoplastic Agents
1
2016
2360
0.020
Why?
Neoplasm Metastasis
1
2009
1056
0.020
Why?
Lymphocytes
1
2007
465
0.020
Why?
Transcription, Genetic
1
2009
1138
0.020
Why?
Cell Line, Tumor
1
2010
2427
0.020
Why?
Lung
1
2009
1170
0.010
Why?
Phenotype
1
2009
2389
0.010
Why?
Epithelial Cells
1
2007
670
0.010
Why?
Mice, Inbred C57BL
1
2009
3111
0.010
Why?
Hemoglobin, Sickle
1
2000
19
0.010
Why?
Splenectomy
1
2000
82
0.010
Why?
Ferritins
1
2000
29
0.010
Why?
Signal Transduction
1
2009
3267
0.010
Why?
Biopsy
1
2000
1163
0.010
Why?
Liver
1
2000
1229
0.010
Why?
Biomarkers
1
2000
1722
0.010
Why?
Golden's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (337)
Explore
_
Co-Authors (45)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_